Skip to main content

Table 1 Clinical data of 166 patients in whom serum lipase was measured at time of admission to hospital or first contact with general practitioner/nephrologist, significant p values were marked in bold

From: Evaluation of lipase levels in patients with nephropathia epidemica - no evidence for acute pancreatitis

Variable

Patients with normal serum lipase

Patients with elevated serum lipase

p

n

141

25

-

Age (years ± SD)

45.3 ± 14.2

57.7 ± 12.2

0.001

Female/male

56/85

6/19

0.798

Onset of symptoms prior to admission to hospital (days)

5.5 (3.6-7.0)

4.5 (3.8-7.3)

0.398

Duration of hospital stay (days)

7.0 (4.0-9.0)

6.5 (5.0-11.0)

0.694

Symptoms

   

Abdominal pain

58/141

9/25

1.000

Back-/flank pain

102/141

17/25

1.000

Headache

96/141

12/25

0.185

Visual disorders

35/141

6/25

0.566

Diarrhea

35/141

7/25

1.000

Nausea/vomiting

69/141

10/25

1.000

Laboratory findings

   

Thrombocytes at admission (×109/L)

105.5 (78.0-172.5)

91.0 (73.5-215.5)

0.233

Minimum thrombocyte level (×109/L)

98.0 (69.8-161.5)

91.0 (73.0-207.5)

0.167

Creatinine at admission (mg/dL [0.5-1.4])

1.7 (1.1-3.5)

2.9 (1.6-5.1)

0.008

Creatinine peak level (mg/dL [0.5-1.4])

2.7 (1.7-4.6)

4.6 (2.7-6.8)

0.025

CrP at admission (mg/dL [0.1-0.4])

4.1 (2.9-7.5)

5.8 (2.5-8.5)

0.871

CrP peak level (mg/dL [0.1-0.4])

4.8 (3.0-8.5)

5.6 (2.4-8.8)

0.792

Lactate dehydrogenase, serum

273.5 (242.0-318.0)

285.0 (239.0-374.5)

0.348

Clinical signs

   

Fever

123/141

21/25

0.280

Blood pressure

   

systolic

130.0 (119.0–140.0)

147.0 (124.8-157.8)

0.010

diastolic

80.0 (70.0–89.0)

80.0 (74.9-97.5)

0.306

Heart rate

76.5 (63.0–88.0)

80.5 (75.5-91.8)

0.471

Abdominal ultrasound

119/141

22/25

0.770

Abdominal CT scan, native

5/141

3/25

0.101